Is uric acid a surrogate and additional component of incident metabolic syndrome, insulin resistance among inactive Central Africans?

作者: B. Longo-Mbenza , H. Nkongo Mvindu , B. Kianu Phanzu , J.B. Kasiam On’Kin , H. Nkakudulu Bikuku

DOI: 10.1016/J.DSX.2010.01.003

关键词:

摘要: Abstract Objective To assess the patterns underlying co-occurrence of components metabolic syndrome defined by IDF criteria and insulin resistance using Factor Analysis. Methods A 5-year patient clinic-based prospective randomized study active versus inactive was conducted among black Africans aged over 40 years at LOMO MEDICAL Center, Kinshasa, DRC. Results Among 282 patients, 1.7%, 12.7%, 2.8%, 15.9%, 10.9%, 15.9% patients were incidence type 2 diabetes, acute stroke, myocardial infarction, resistance, syndrome + insulin hyperuricemia. Male gender, physical inactivity, high Hs-CRP abdominal obesity independent predictors Obesity factor (hip circumference, BMI, WC), (HOMA index insulin), dysglycemia/dyslipidemia (glucose, LDL, HDL, total cholesterol, triglycerides) inflammation (Hs-CRP) identified explained a variance 79% on analysis in with resistance. In isolated syndrome, fat distribution, disorders (WC, triglycerides, glucose uric acid, HDL) blood pressure two factors explaining 55% model. Conclusion Uric acid may be considered as an additional component without

参考文章(41)
World Health Organization, International Society of Hypertension Writing Group, None, 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension. ,vol. 21, pp. 1983- 1992 ,(2003) , 10.1097/00004872-200311000-00002
Targher G, Zenere Mb, Branzi P, Saggiani F, Travia D, Bonora E, Zenti Mg, Muggeo M, Santi L, Tosi F, Cacciatori, Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. International Journal of Obesity. ,vol. 20, pp. 975- 980 ,(1996)
Shun-Sheng Chen, Ming-Chao Peng, Chih-Cheng Huang, Wen-Chung Tsai, Jia-Shou Liu, Wei-Hsi Chen, Yung-Yee Chang, The serum uric acid and related cardiovascular risk factors in south Taiwan. Southeast Asian Journal of Tropical Medicine and Public Health. ,vol. 36, pp. 259- 264 ,(2005)
Linda S. Pescatello, Deborah Riebe, Ross Arena, Paul D. Thompson, ACSM's Guidelines for Exercise Testing and Prescription ,(2020)
G. A. Rose, Henry W. Blackburn, Cardiovascular survey methods East African Medical Journal. ,vol. 46, pp. 220- 227 ,(1968)
J. Tuomilehto, H. Gareeboo, P. Z. Zimmet, A. M. Hodge, G. K. Dowse, K. G.M.M. Alberti, Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. International Journal of Obesity. ,vol. 20, pp. 137- 146 ,(1996)
B.Charles Solymoss, Martial G Bourassa, Lucien Campeau, Allan Sniderman, Michel Marcil, Jacques Lespérance, Sylvie Lévesque, Susan Varga, Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity American Journal of Cardiology. ,vol. 93, pp. 159- 164 ,(2004) , 10.1016/J.AMJCARD.2003.09.032
Teh-Ling Liou, Ming-Wei Lin, Li-Chuan Hsiao, Ting-Ting Tsai, Wan-Leong Chan, Low-Tone Ho, Chii-Min Hwu, Is Hyperuricemia Another Facet of the Metabolic Syndrome Journal of The Chinese Medical Association. ,vol. 69, pp. 104- 109 ,(2006) , 10.1016/S1726-4901(09)70186-8
F.Javier Nieto, Carlos Iribarren, Myron D. Gross, George W. Comstock, Richard G. Cutler, Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. ,vol. 148, pp. 131- 139 ,(2000) , 10.1016/S0021-9150(99)00214-2